Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 13, 2019Frontiers in Aging NeuroscienceOpen Access

Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLi CaoNanjing University of Finance and EconomicsYDYanping DaiShenyang Institute of Automation

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cao et al. (2019) studied this question.

synapsesocial.com/papers/6a9515b11fe04514d10f4013https://doi.org/10.3389/fnagi.2019.00254
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction2015 · 168 citations
  2. 2Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration2019 · 187 citations
  3. 3CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival2014 · 271 citations
  4. 4Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease2018 · 321 citations
  5. 5Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total‐tau, phosphorylated‐tau, NFL, neurogranin, and YKL‐402018 · 140 citations